Rockwell Automation to enhance its global resources to help life science industry
Mumbai, June 16, 2021:
Rockwell Automation India stated that it will continue to enhance its global resources, both infrastructure and domain expertise, to help the life sciences industry.
The company aims to improve the quality of life by making the world more productive and sustainable and is committed to enable the next generation of smart manufacturing.
The company stated that techniques such as deep learning and advanced data visualisation allow researchers to learn on the body of existing research undertaken to tackle the complexities involved in discovering suitable treatments for novel viruses.
"We have extensive experience in providing integrated automation and information solutions. These solutions help life science manufacturers achieve greater efficiencies, lower life-cycle costs, maintain product quality, and adhere to strict cGMP requirements. We work with top biotech, pharma, and device manufacturers to make their facility of the future a reality today”, stated Ruchi Mathur, head – commercial marketing, Rockwell Automation India Pvt. Ltd.
The company added that it is evolving its service and solutions, capabilities and launching a new brand: LifecycleIQ Services. The new brand represents the expanding ways that customers can engage with Rockwell Automation technology and highly trained professionals to improve their performance and reimagine what’s possible across their industrial value chain.
Mathur added, “We work alongside life sciences leaders every day to develop digital transformation strategies that move them beyond a piecemeal approach implementation. Together, we help them harness agility and connectivity as a business accelerant so that we can rethink every step of drug development and manufacturing so as to help them realize economies of scale with flexibility, efficiency and confidence.”
The company stated that through the use of artificial intelligence (AI), digital twin and other advanced analytic technologies, the pharma/biotech manufacturers can rapidly accelerate the path towards the development and dissemination of such treatments.
The utility of AI extends through to production and distribution, where manufacturers play a powerful role in getting these medicines into the field at rapid speed and amid conditions of great uncertainty. Pharmabiz